Encore Dermatology Revenue and Competitors

USA

Location

$76.7M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Encore Dermatology's estimated annual revenue is currently $502.5k per year.(i)
  • Encore Dermatology's estimated revenue per employee is $100,500
  • Encore Dermatology's total funding is $76.7M.

Employee Data

  • Encore Dermatology has 5 Employees.(i)
  • Encore Dermatology grew their employee count by -17% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Encore Dermatology?

Headquartered in Malvern, Pennsylvania, Encore Dermatology is a privately held fully integrated dermatology company with a mission committed to delivering innovative prescription therapies and medical devices to dermatologists focusing on customer service and improving the quality-of-life of patients. Encore has a wide range of medical dermatology products, treating a number of topical disease states such as acne and atopic dermatitis. Encore Dermatology is rapidly expanding through acquisitions, in- licensing and co-marketing opportunities.

keywords:N/A

$76.7M

Total Funding

5

Number of Employees

$502.5k

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Encore Dermatology News

2022-04-19 - Dermatitis Market Player Collaborations Help Drive Growth Rate At 8%

... Bayer HealthCare, Encore Dermatology Inc., Meda Pharmaceuticals, Allergan Plc. (Republic of Ireland) and Bristol-Myers Squibb.

2022-04-17 - Eczema Therapeutics Market – What are the Driving Factors ...

... Factors and How Companies are Responding Accordingly | Sanofi S.A., Encore Dermatology Inc, AbbieVie Inc., F. Hoffmann-La Roche AG,.

2022-04-17 - Atopic Dermatitis Market Size And Market Growth ...

... AbbVie Inc., Encore Dermatology, Inc., Astellas Pharma Inc., Mylan N.V., AstraZeneca, 3M, and Teva Pharmaceutical Industries Ltd.

2019-04-09 - Encore Dermatology Receives $20M Venture Loan Facility from Horizon Technology Finance

Encore Dermatology, Inc., a Malvern, Pennsylvania-based dermatologically-focused specialty pharmaceutical company, received a $20m venture loan facility from Horizon Technology Finance Corporation (NASDAQ: HRZN). $15m out of the total financing has been initially funded. The capital will enabl ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M5N/AN/A
#2
$0.3M5N/AN/A
#3
$0.5M5N/AN/A
#4
$0.5M5N/AN/A
#5
$0.5M5-17%N/A